Virbac Cat Advanced Kidney & Joint

Virbac HPM — Cat Advanced Kidney & Joint 

The senior cat clinical diet that addresses both conditions at once. Virbac HPM Cat Advanced Kidney & Joint is a veterinary clinical nutrition dry cat food specifically formulated for the two most prevalent and frequently co-occurring conditions in senior cats — chronic kidney disease (CKD) and joint disease (osteoarthritis). These conditions are not coincidental companions — they share common risk factors, common inflammatory mechanisms, and common patient demographics. The senior cat who develops CKD is the same cat who develops joint disease — and managing one condition while ignoring the other produces incomplete clinical outcomes. Virbac HPM addresses both simultaneously through a precisely calibrated nutritional strategy that navigates the most challenging tension in feline clinical nutrition: kidney diets require controlled protein to reduce renal workload, but joint disease requires adequate protein to maintain the lean muscle mass that supports joint function and mobility. Virbac HPM Cat Advanced Kidney & Joint resolves this tension through high-quality, highly digestible protein at precisely controlled levels — providing adequate amino acids for muscle maintenance while minimizing the uremic toxin load on compromised kidneys. Available in 400g (trial size) and 1.5kg.

Why Virbac HPM Cat Advanced Kidney & Joint Is The Best Choice

• Dual Clinical Indication — Simultaneously addresses chronic kidney disease (CKD) and joint disease (osteoarthritis) — the two most prevalent co-occurring conditions in senior cats.
• Controlled High-Quality Protein — The most clinically precise aspect of the formula — protein is controlled to reduce renal workload while remaining adequate for lean muscle maintenance that supports joint function.
• Phosphorus Restriction — Reduced phosphorus is the single most important dietary intervention for slowing CKD progression — the Virbac HPM formula provides clinically appropriate phosphorus restriction.
• Omega-3 (EPA & DHA) — Dual Benefit — Omega-3 fatty acids provide anti-inflammatory benefit for both kidney disease (reducing renal inflammation) and joint disease (reducing synovial inflammation and cartilage degradation).
• Joint Support Nutrients — Glucosamine and chondroitin sulfate supporting cartilage integrity and synovial fluid quality — the structural joint support nutrients that reduce pain and improve mobility.
• Antioxidants — Renal & Joint Protection — Vitamins E and C, selenium — reducing oxidative stress that accelerates both kidney damage and cartilage degradation.
• Alkalizing Effect — Metabolic acidosis is a common complication of CKD — the formula's alkalizing effect supports acid-base balance and reduces the muscle wasting that acidosis causes.
• High Palatability — Clinical diets are only effective if the cat eats them — the Virbac HPM formula is formulated for high palatability to ensure consistent consumption by cats who may have reduced appetite secondary to CKD.
• Two Sizes — 400g trial size for initial introduction; 1.5kg for ongoing management.
• Virbac HPM — Veterinary Expertise — From one of the world's leading animal health companies.

(Visual asset placement: flat-lay of both the 400g and 1.5kg Virbac HPM bags, or lifestyle photo of a comfortable senior cat — communicating the quality of life that effective clinical management supports.)

Product Details & Features

The Senior Cat — Why CKD and Joint Disease Co-Occur Chronic kidney disease and osteoarthritis are the two most prevalent conditions in senior cats — and they frequently occur together in the same patient for interconnected reasons:

Prevalence:

• CKD affects approximately 30–40% of cats over 10 years of age and up to 80% of cats over 15 years
• Osteoarthritis affects approximately 60–90% of cats over 10 years of age — significantly underdiagnosed because cats hide pain effectively

Shared risk factors:

• Age — Both conditions are age-related — the same aging processes that cause kidney nephron loss also cause cartilage degradation
• Chronic inflammation — Systemic chronic inflammation drives both renal fibrosis (CKD progression) and synovial inflammation (joint disease progression)
• Oxidative stress — Free radical damage accelerates both kidney cell death and cartilage degradation
• Reduced physical activity — Joint pain reduces activity, which reduces muscle mass, which reduces joint support, which worsens joint pain — a vicious cycle that also reduces renal perfusion

The clinical challenge: Managing CKD and joint disease simultaneously creates a nutritional tension that standard single-indication diets cannot resolve:

• Kidney diets restrict protein to reduce uremic toxin production — but protein restriction risks muscle wasting that worsens joint disease
• Joint support diets provide adequate protein for muscle maintenance — but standard protein levels increase renal workload in CKD cats

Virbac HPM Cat Advanced Kidney & Joint resolves this tension through precise formulation — the right protein quality and quantity for both conditions simultaneously.

The Kidney Disease Strategy

Phosphorus restriction — The most important intervention: Phosphorus retention is the primary driver of CKD progression — as kidney function declines, the kidneys cannot excrete phosphorus efficiently, leading to hyperphosphatemia (elevated blood phosphorus). Hyperphosphatemia:

• Directly damages remaining kidney nephrons — accelerating CKD progression
• Causes renal secondary hyperparathyroidism — further damaging kidney tissue
• Contributes to soft tissue mineralization — including renal mineralization

Dietary phosphorus restriction is the single most evidence-based nutritional intervention for slowing CKD progression. The Virbac HPM formula provides clinically appropriate phosphorus restriction — the most important reason to use a clinical kidney diet rather than a standard commercial food.

Controlled protein — Reducing uremic toxin load: Protein metabolism produces uremic toxins (urea, creatinine, indoxyl sulfate, p-cresol sulfate) that the kidneys must excrete. In CKD, reduced kidney function means these toxins accumulate — causing the clinical signs of uremia (nausea, reduced appetite, lethargy, vomiting). Controlled dietary protein reduces the production of uremic toxins — reducing the uremic burden on compromised kidneys.

The protein quality imperative: Protein restriction only works if the protein provided is of the highest quality — providing all essential amino acids in the minimum amount required, with minimal waste products. Low-quality protein at restricted levels risks essential amino acid deficiency. The Virbac HPM formula uses high-quality, highly digestible protein sources that provide complete amino acid nutrition at controlled levels.

Omega-3 for renal protection: EPA and DHA provide specific renal benefits:

• Anti-inflammatory — Reducing the renal inflammation that drives fibrosis and nephron loss
• Vasodilatory — Improving renal blood flow — supporting the perfusion of remaining functional nephrons
• Anti-proteinuric — Reducing protein loss in the urine — a marker of renal damage

Alkalizing effect — Managing metabolic acidosis: CKD causes metabolic acidosis — the kidneys cannot excrete sufficient acid, leading to blood pH decline. Metabolic acidosis:

• Causes muscle wasting — the body catabolizes muscle protein to buffer the acid load
• Accelerates CKD progression — acidosis directly damages kidney tubular cells
• Reduces appetite and quality of life

The Virbac HPM formula's alkalizing effect supports acid-base balance — reducing the muscle wasting and quality of life impact of metabolic acidosis.

The Joint Disease Strategy

Glucosamine & Chondroitin Sulfate — Cartilage Support: Glucosamine and chondroitin sulfate are the structural building blocks of cartilage and synovial fluid:

Glucosamine:

• A precursor to glycosaminoglycans — the structural components of cartilage matrix
• Supports chondrocyte (cartilage cell) function — stimulating the production of new cartilage matrix components
• Has mild anti-inflammatory properties — reducing the synovial inflammation that drives cartilage degradation

Chondroitin sulfate:

• A major structural component of cartilage — providing the compressive strength and elasticity that allows cartilage to absorb impact
• Inhibits the enzymes (matrix metalloproteinases) that degrade cartilage matrix — slowing cartilage loss
• Supports synovial fluid viscosity — improving joint lubrication and reducing friction

Omega-3 for joint protection: EPA and DHA provide specific joint benefits — the same Omega-3 that supports kidney health also supports joint health:

• Anti-inflammatory — EPA directly inhibits the inflammatory pathways (COX-2, leukotriene) that drive synovial inflammation and cartilage degradation
• Cartilage protection — Reducing the inflammatory mediators that activate cartilage-degrading enzymes
• Pain reduction — The anti-inflammatory effect reduces joint pain — improving mobility and quality of life

Protein adequacy for muscle maintenance: Lean muscle mass is the primary support structure for joints — adequate muscle mass:

• Absorbs impact before it reaches the joint
• Stabilizes the joint during movement — reducing abnormal loading that accelerates cartilage wear
• Supports the range of motion that maintains joint health

The Virbac HPM formula provides protein at levels adequate for lean muscle maintenance — ensuring the joint support benefit of muscle mass is preserved despite the protein control required for kidney disease.

Antioxidants — Dual Renal and Joint Protection: Oxidative stress drives both CKD progression and cartilage degradation:

• Vitamin E — Fat-soluble antioxidant protecting cell membranes from oxidative damage in both kidney cells and chondrocytes
• Vitamin C — Water-soluble antioxidant supporting immune function and collagen synthesis — collagen is a structural component of both kidney tissue and cartilage
• Selenium — Antioxidant mineral supporting the glutathione peroxidase system — the body's primary intracellular antioxidant defense

Palatability — The Clinical Compliance Challenge Cats with CKD frequently have reduced appetite — a consequence of uremic toxin accumulation, nausea, and metabolic acidosis. A clinical diet that the cat refuses to eat provides no benefit — and force-feeding a clinical diet can create food aversions that make future dietary management impossible.

The Virbac HPM Cat Advanced Kidney & Joint formula is specifically formulated for high palatability — ensuring that cats with reduced appetite secondary to CKD will consume adequate amounts of the clinical diet. This palatability focus is as clinically important as the nutritional formulation.

The 400g Trial Size — Clinical Introduction Strategy The 400g size serves a specific clinical purpose — it allows veterinarians and cat owners to introduce the clinical diet and assess palatability before committing to the larger 1.5kg bag. For cats with CKD who may be selective about food, the trial size reduces the financial risk of palatability rejection.

CKD Staging and Dietary Management The International Renal Interest Society (IRIS) staging system classifies CKD into four stages based on creatinine and SDMA levels:

The Virbac HPM Cat Advanced Kidney & Joint formula is appropriate for IRIS Stage 2–4 CKD — the stages where dietary management has the most significant impact on disease progression and quality of life.

(Visual asset placement: flat-lay of both the 400g and 1.5kg bags, or lifestyle photo of a comfortable, mobile senior cat — communicating the quality of life improvement that effective kidney and joint management provides.)

Specifications & Feeding

Feeding Guidelines

Divide daily amount into 2–3 meals. Always provide fresh water — hydration is particularly critical for cats with CKD. Adjust based on body condition and veterinarian's recommendation.

Transition Guidelines

Transition slowly — cats with CKD may be food-averse. If the cat refuses the new food, slow the transition further. Never force-feed a clinical diet — food aversion can make future dietary management impossible.

Serving Tips

• Always provide fresh water — Hydration is the most important supportive measure for CKD cats — consider a water fountain to encourage drinking
• Warm slightly before serving — Warming the kibble slightly (10 seconds in microwave) releases aromas that improve palatability for cats with reduced appetite
• Small, frequent meals — 3–4 small meals per day rather than 2 large meals — reduces the uremic toxin load per meal and supports appetite in nauseous cats
• Never mix with high-phosphorus foods — Avoid mixing with standard cat food, treats, or table scraps that would undermine the phosphorus restriction
• Monitor body weight monthly — CKD cats are at risk of weight loss — monthly weigh-ins allow early intervention

The Complete Virbac HPM Cat Range at petfast.shop

Kidney Protection. Joint Support. Senior Cat Precision. — Backed by petfast.shop

At petfast.shop, Virbac HPM Cat Advanced Kidney & Joint is the clinical diet we recommend for senior cat owners managing the two conditions that most commonly co-occur in aging cats — chronic kidney disease and osteoarthritis. Phosphorus restriction to slow CKD progression. Controlled high-quality protein to reduce uremic toxin load while preserving muscle mass. Omega-3 for renal and joint anti-inflammatory benefit. Glucosamine and chondroitin for cartilage support. Antioxidants for dual renal and joint protection. Available in 400g trial size and 1.5kg. Delivered fast across Egypt from petfast.shop. Because your senior cat deserves the clinical precision that addresses both conditions simultaneously — and Virbac HPM delivers exactly that.

Kidney protection. Joint support. Senior cat precision. Add Virbac HPM Cat Advanced Kidney & Joint to your cart today — veterinary clinical dry cat food for CKD and joint disease, delivered fast across Egypt from petfast.shop.